p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
About this item
Full title
Author / Creator
Kojonazarov, Baktybek , Novoyatleva, Tatyana , Boehm, Mario , Happe, Chris , Sibinska, Zaneta , Tian, Xia , Sajjad, Amna , Luitel, Himal , Kriechling, Philipp , Posern, Guido , Evans, Steven M , Grimminger, Friedrich , Ghofrani, Hossein A , Weissmann, Norbert , Bogaard, Harm J , Seeger, Werner and Schermuly, Ralph T
Publisher
United States: American Thoracic Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Thoracic Society
Subjects
More information
Scope and Contents
Contents
Although p38 mitogen-activated protein kinase (MAPK) is known to have a role in ischemic heart disease and many other diseases, its contribution to the pathobiology of right ventricular (RV) hypertrophy and failure is unclear. Therefore, we sought to investigate the role of p38 MAPK in the pathophysiology of pressure overload-induced RV hypertrophy...
Alternative Titles
Full title
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1914849251
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1914849251
Other Identifiers
ISSN
1044-1549
E-ISSN
1535-4989
DOI
10.1165/rcmb.2016-0374OC
